Role of surgery in the management of head and neck cancer: A contemporary view of the data in the era of organ preservation

Journal of Laryngology and Otology

Volumn 127, Issue 2, 2013, Pages 121-127

  Hormann K ^a   Sadick, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

General Surgery; Head And Neck Neoplasms; Organ Preservation; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LARYNX DISORDER; MOUTH CANCER; ORGAN PRESERVATION; OROPHARYNX CANCER; PRACTICE GUIDELINE; RADIATION DOSE; REVIEW; TONGUE CANCER; HEAD AND NECK NEOPLASMS; MORTALITY; PROCEDURES; SURVIVAL RATE; TREATMENT OUTCOME;

HEAD AND NECK NEOPLASMS; HUMANS; ORGAN PRESERVATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84876888343     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215112002988     Document Type: Review

References (68)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30 (See also Erratum, CA Cancer J Clin 2005;55:259
2. Saunders MI, Rojas AM. Management of cancer of the head and neck- A cocktail with your PORT N Engl J Med 2004;350: 1997-9
3. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005;103:1843-9
4. Watts SL, Brewer EE, Fry TL. Human papilloma virus DNA types in squamous cell carcinomas of the head and neck. Oral Surg Oral Med Oral Pathol 1991;71:701-7
5. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85: 95-111
6. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94
7. Laramore GE, Scott CB, Al-Sarraf M, Haselow RE, Ervin TJ, Wheeler R et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992;23:705-13
8. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806-16
9. Gourin CG, Johnson JT. A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the head and neck. Laryngoscope 2009;119: 2124-34
10. Department of Veterans Affairs Laryngeal Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced larnygeal cancer. N Engl J Med 1991;324:1685-90
11. Wong RJ, Shah JP. The role of the head and neck surgeon in contemporary multidisciplinary treatment programs for advanced head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2010;18:79-82
12. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006;116:1-13
13. National Comprehensive Cancer Network. In: http://www. NCCN.org [17 August 2012]
14. Sassler AM, Esclamado RM,Wolf GT. Surgery after organ preservation therapy. Arch Otolaryngol Head Neck Surg 1995;121: 162-5
15. Mäkitie AA, Koivunen P, HarriKeski-Säntti H, Törnwall J, Pukkila M, Laranne J et al. Oral tongue carcinoma and its treatment in Finland. Eur Arch Otorhinolaryngol 2007;264:263-7
16. Sessions DG, Spector GJ, Lenox J, Haughey B, Chao C,Marks J. Analysis of treatment results for oral tongue cancer. Laryngoscope 2002;112:616-25
17. WolfensbergerM, Zbaeren P, Dulguerov P,MüllerW, Arnoiux A, Schmid S. Surgical treatment of early oral carcinoma-results of a prospective controlled multicenter study. Head Neck 2001;23: 525-30
18. Walvekar RR, Li RJ, Gooding WE, Gibson MK, Heron D, Johnson JT et al. Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx. Laryngoscope 2008;118:2129-34
19. O'Hara J, MacKenzie K. Surgical versus non-surgical management of early stage oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2011;268:437-42
20. Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Malyapa RS, Werning JW. Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol 2006;29:290-7
21. Roosli C, Tschudi DC, Studer G, Braun J, Stoeckli SJ. Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx. Laryngoscope 2009;119:534-40
22. Cosmidis A, Rame JP, Dassonville O. T1-T2 N0 oropharyngeal cancers treated with surgery alone. A GETTEC study. Eur Arch Otorhinolaryngol 2004;261:276-81
23. Galati LT, Myers EN, Johnson JT. Primary surgery for early SCC of the tonsil. Head Neck 2000;22:294-6
24. Lusinchi A, Wibault P, Marandas P, Kunkler I, Eschwege F. Exclusive radiation therapy: the treatment of early tonsillar tumors. Int J Radiat Oncol Biol Phys 1989;17:273-7
25. Palme CE, Gullane PJ, Gilbert RW. Current treatment options in squamous cell carcinoma of the oral cavity. Surg Oncol Clin N Am 2004;13:47-70
26. Marur S, Forastiere A. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008;83: 489-501
27. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44
28. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY. Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer 2006;107:337-44
29. Udoff RA, Elam JC, Gourin CG. Primary surgery for oropharyngeal cancer. Otolaryngol Head Neck Surg 2010;143:644-9
30. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52
31. Lang S,Wollenberg B, Dellian M, Steuer-Vogt MK, Schwenzer K, Sautier W. Clinical and epidemiological data of patients with malignomas of the head and neck [in German]. Laryngorhinootologie 2002;81:499-508
32. Steiner W, Ambrosch P, Hess CF, Kron M. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 2001;124:58-67
33. TakesRP, StrojanP,SilverCE, BradleyPJ, HaigentzMJr,WolfGT. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 2012;34:270-81
34. Kraus DH, Zelefsky MJ, Brock HA, Huo J, Harrison LB, Shah JP. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg 1997;116:637-41
35. Bova R, Goh R, Poulson M, Coman WB. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review. Laryngoscope 2005;115:864-9
36. Ogura JH, Marks JE, Freeman RB. Results of conservation surgery for cancers of the supraglottis and pyriform sinus. Laryngoscope 1980;90:591-600
37. Chevalier D, Watelet JB, Darras JA, Piquet JJ. Supraglottic hemilaryngopharyngectomy plus radiation for the treatment of early lateral margin and pyriform sinus carcinoma. Head Neck 1997;19:1-5
38. Makeieff M, Mercante G, Jouzdani E, Garrel R, Crampette L, Guerrier B. Supraglottic hemipharyngolaryngectomy for the treatment of T1 and T2 carcinomas of laryngeal margin and piriform sinus. Head Neck 2004;26:701-5
39. Martin A, Jackel MC, Christiansen H, Mahmoodzada M, Kron M, Steiner W. Organ preserving transoral laser microsurgery for cancer of the hypopharynx. Laryngoscope 2008;118: 398-402
40. Godballe C, Jørgensen K, Hansen O, Bastholt L. Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery. Laryngoscope 2002;112:834-8
41. Rabbani A, Amdur RJ, Mancuso AA, Werning JW, Kiwan J, Morris CG et al. Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus. Int J Radiat Oncol Biol Phys 2008;72:351-5
42. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. tEORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996;88: 890-9
43. Wei WI. The dilemma of treating hypopharyngeal carcinoma: more or less. Arch Otolaryngol Head Neck Surg 2002;128: 229-32
44. Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, FeeWE et al. Hypopharyngeal patient care evaluation. Laryngoscope 1997;107:1005-17
45. Ho CM, Lam KH, Wei WI, Yuen PW, Lam LK. Squamous cell carcinoma of the hypopharynx-analysis of treatment results. Head Neck 1993;15:405-12
46. Gourin CG, Terris DJ. Carcinoma of the hypopharynx. Surg Oncol Clin N Am 2004;13:81-98
47. Arriagada R, Eschwege F, Cachin Y, Richard JM. The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers. Cancer 1983;51:1819-25
48. Mirimanoff RO, Wang CC, Doppke KP. Combined surgery and postoperative radiation therapy for advanced laryngeal and hypopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 1985;11:499-504
49. Zelefsky MJ, Kraus DH, Pfister DG, Raben A, Shah JP, Strong EW et al. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 1996;18:405-11
50. Adelstein DJ, Saxton JP, Lavertu PI, Tuason L, Wood BG, Wanamaker JR et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997;19:567-75
51. Samant S, Kumar P,Wan J, Hanchett C, Vieira F, Murry T et al. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck 1999;21:595-601
52. Lee MS, Ho H-C, Hsiao S-H, Hwang J-H, Lee C-C, Hung S-K. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer. Acta Otolaryngol 2008;128:103-9
53. Pearson BW, DeSanto LW, Olsen KD, Salassa JR. Results of near-total laryngectomy. Ann Otol Rhinol Laryngol 1998;107: 820-5
54. Ambrosch P, Fazal A. Functional organ preservation in laryngeal and hypopharyngeal cancer [in German]. Laryngorhinootologie 2011;90(suppl 1):S83-109
55. Eckel HE. Local recurrences following transoral laser surgery for early glottic carcinoma: frequency, management, and outcome. Ann Otol Rhinol Laryngol 2001;110:7-15
56. Eckel HE, Thumfart WF, Jungehülsing M, Sittel C, Stennert E. Transoral laser surgery for early glottic carcinoma. Eur Arch Otorhinolaryngol 2000;257:221-6
57. Ambrosch P, Rödel R, Kron M, Steiner W. The transoral laser microsurgery of laryngeal carcinomas. A retrospective study of cases [in German]. Onkologe 2001;7:505-12
58. Motta G, Esposito E, Motta S, Tartaro G, Testa D. CO2 laser surgery in the treatment of glottic cancer. Head Neck 2005;27: 566-74
59. Sjögren EV, van Rossum MA, Langeveld TPM, Voerman MS, van de Kamp VAH, Friebel MOW et al. Voice outcome in T1a midcord glottic carcinoma. Arch Otolaryngol Head Neck Surg 2008;134:965-72
60. Peretti G, Piazza C, Cocco D, De Benedetto L, Del Bon F, Redaelli De Zinis LO et al. Transoral CO(2) laser treatment for T(is)-T(3) glottic cancer: the University of Brescia experience on 595 patients. Head Neck 2010;32:977-83
61. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001;19:4029-36
62. Johansen LV, Grau C, Overgaard J. Glottic carcinoma-patterns of failure and salvage treatment after curative radiotherapy in consecutive patients. Radiother Oncol 2002;63:257-67
63. Smee RI, Meagher NS, Williams JR, Broadley K, Bridger GP. Role of radiotherapy in early glottic carcinoma. Head Neck 2010;32:850-9
64. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al. Concurrent chemotherapy and radiation for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8
65. Weber RS, Berkey BA, ForastiereA,Cooper J, Maor M, Goepfert H et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg 2003;129:44-9
66. American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006;24:3693-704
67. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003;66:253-62
68. Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008;26:3582-9